Jackie Parker

Jackie Parker has a solid work experience in the pharmaceutical industry. Jackie began their career as a Clinical Research Associate at Novella Clinical in 2008. In 2011, they joined Biogen, where they held various roles, including Associate Clinical Trial Manager and Manager of Site Monitoring Quality and Oversight. From 2014 to 2017, Jackie served as the Sr. Manager of Site Monitoring and Management at Biogen. In 2017, they moved to Bioverativ, a Sanofi company, as an Executive Director of R&D Quality. Since 2019, Jackie has been working at TG Therapeutics, Inc., first as a Senior Director of Clinical Quality, then as the Vice President of Clinical Quality, and currently as the VP of R&D Quality and Pharmacovigilance.

Jackie Parker earned a Bachelor of Science degree in Biology and Anatomy from Duke University, where they studied from 2001 to 2005. Later, they pursued a Master's degree in Public Health from the University of North Carolina at Chapel Hill, completing their studies from 2008 to 2011.